Cargando…

Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection

Detalles Bibliográficos
Autores principales: Sarode, Gargi S., Sarode, Sachin C., Gadbail, Amol R., Gondivkar, Shailesh, Kumar Sharma, Nilesh, Patil, Shankargouda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422813/
https://www.ncbi.nlm.nih.gov/pubmed/33254501
http://dx.doi.org/10.1016/j.mehy.2020.110179
_version_ 1783570073658589184
author Sarode, Gargi S.
Sarode, Sachin C.
Gadbail, Amol R.
Gondivkar, Shailesh
Kumar Sharma, Nilesh
Patil, Shankargouda
author_facet Sarode, Gargi S.
Sarode, Sachin C.
Gadbail, Amol R.
Gondivkar, Shailesh
Kumar Sharma, Nilesh
Patil, Shankargouda
author_sort Sarode, Gargi S.
collection PubMed
description
format Online
Article
Text
id pubmed-7422813
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74228132020-08-13 Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection Sarode, Gargi S. Sarode, Sachin C. Gadbail, Amol R. Gondivkar, Shailesh Kumar Sharma, Nilesh Patil, Shankargouda Med Hypotheses Letter to Editors Elsevier Ltd. 2020-11 2020-08-12 /pmc/articles/PMC7422813/ /pubmed/33254501 http://dx.doi.org/10.1016/j.mehy.2020.110179 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to Editors
Sarode, Gargi S.
Sarode, Sachin C.
Gadbail, Amol R.
Gondivkar, Shailesh
Kumar Sharma, Nilesh
Patil, Shankargouda
Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection
title Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection
title_full Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection
title_fullStr Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection
title_full_unstemmed Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection
title_short Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection
title_sort patients with interferon expressing oral pathologies are susceptible to covid-19 infection
topic Letter to Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422813/
https://www.ncbi.nlm.nih.gov/pubmed/33254501
http://dx.doi.org/10.1016/j.mehy.2020.110179
work_keys_str_mv AT sarodegargis patientswithinterferonexpressingoralpathologiesaresusceptibletocovid19infection
AT sarodesachinc patientswithinterferonexpressingoralpathologiesaresusceptibletocovid19infection
AT gadbailamolr patientswithinterferonexpressingoralpathologiesaresusceptibletocovid19infection
AT gondivkarshailesh patientswithinterferonexpressingoralpathologiesaresusceptibletocovid19infection
AT kumarsharmanilesh patientswithinterferonexpressingoralpathologiesaresusceptibletocovid19infection
AT patilshankargouda patientswithinterferonexpressingoralpathologiesaresusceptibletocovid19infection